Study ID: TV50717-CNS-30047 | 2016-000630-22
Study Title
- Evaluation of Safety and Tolerability of Long-term TEV-50717 (Deutetrabenazine) for Treatment of Tourette Syndrome in Children and Adolescents
Teva Identifier
- TV50717-CNS-30047 | 2016-000630-22
ClinicalTrials.gov Identifier
- NCT03567291
Study Status
- Terminated
Trial Condition(s)
- Tourette Syndrome
Interventions
- Drug: TEV-50717 | Drug: Placebo
Study Description
- Please refer to ClinicalTrials.gov for a description of the trial

Key Participation Requirements
Gender
- Female, Male
Age Range
- 6 Years to 17 Years
Trial Duration
- May 25, 2018 - May 15, 2020
Phase
- Phase 3
Study Type
Interventional